Specialist Nurse Management Programmes
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (4) , 225-240
- https://doi.org/10.2165/00019053-200321040-00001
Abstract
Chronic heart failure (CHF) is a modern-day epidemic in most developed countries. As such, it is both common and costly. Contrary to the impression given by clinical trial data, CHF mainly affects older individuals with approximately equal numbers of men and women and concurrent disease profiles likely to complicate or even prohibit the application of proven treatments. It is within this context that there has been an increasing interest in specific CHF-management programmes designed to limit costly hospital use in typically older individuals at high risk for poor quality of life, recurrent readmissions and premature death. This paper examines the evidence to suggest that CHF programmes involving individualised multidisciplinary post-discharge healthcare, with a major focus on specialist nurse management to ensure that the patient receives optimal treatment, are clinically and economically effective in reducing the typical burden imposed by CHF. These programmes appear to be most effective in ‘high-risk’ patients who typically have recurrent readmissions in high-cost units. Overall, the literature suggests that these programmes are able to reduce recurrent hospital stay by 30–50% relative to usual care (even in the presence of gold-standard treatment) in the short to medium term with comparable cost benefits. Recent data from a management programme involving a cohort of typically older and fragile patients with CHF in Australia showed that at 3 years post index admission, hospital utilisation costs were reduced by one-third relative to usual care. The potential for enormous cost benefits (both in terms of absolute cost savings and in terms of facilitating a more efficient healthcare system) if a specialist nurse programme of care was applied in the form of a UK-wide heart failure service was also recently examined. Based on year 2000 activity levels, it was found that for each specialist heart failure nurse appointed in the UK (with a caseload of 200–250 patients per annum), nominal savings of £49 000 per annum could be generated in order to make the healthcare system more efficient.Keywords
This publication has 99 references indexed in Scilit:
- Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United KingdomInternational Journal of Cardiology, 2005
- Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?Heart, 2002
- Failing ageing heartsPublished by Oxford University Press (OUP) ,2001
- Reduced costs with bisoprolol treatment for heart failure; an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)Published by Oxford University Press (OUP) ,2001
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?European Heart Journal, 2001
- The Effects of an Advanced Practice Nurse-Directed Heart Failure ProgramThe Nurse Practitioner, 2000
- Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failureThe American Journal of Cardiology, 1999
- Evaluation of cost and hospitalization outcomes from a community case management program serving heart failure clientsJournal of Cardiac Failure, 1998
- An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) StudyPharmacoEconomics, 1997
- Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failureAmerican Heart Journal, 1995